Sinobiom Overview
- Year Founded
-
2007
- Status
-
Private
- Employees
-
135
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$30.9M
- Investors
-
2
Sinobiom General Information
Description
Developer and producer of biomaterials based on controllable polymer polymerization technology and multi-factor polymer physical modification technology. The company is mainly engaged in the research and production of medical-grade biodegradable polymer materials for passive implanted medical devices, such as orthopedics, sports medicine, 3D printing, plastic surgery, neurosurgery, and oral cavity.
Contact Information
Website
www.sinobiom.comCorporate Office
- No. 666A, Chaoqun Street
- High-tech Industrial Development Zone
- Changchun, Jilin
- China
Corporate Office
- No. 666A, Chaoqun Street
- High-tech Industrial Development Zone
- Changchun, Jilin
- China
Sinobiom Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC (Series B) | 16-Jul-2021 | $30.9M | Completed | Generating Revenue | ||
| 1. Later Stage VC (Series A) | 23-Dec-2019 | Completed | Generating Revenue |
Sinobiom Patents
Sinobiom Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026086180-A1 | Use of poly (l-lactide) or copolymer comprising l-lactic acid repeating units in prevention or treatment of obesity-related diseases | Pending | 24-Oct-2024 | ||
| WO-2026051079-A1 | Hair growth | Pending | 09-Sep-2024 | ||
| AU-2024296915-A1 | Polylactic acid and use of copolymer thereof in preparation of drug for promoting nerve growth and repair | Pending | 12-Jul-2023 | ||
| EP-4744670-A1 | Polylactic acid and use of copolymer thereof in preparation of drug for promoting nerve growth and repair | Pending | 12-Jul-2023 | ||
| WO-2025011563-A1 | Polylactic acid and use of copolymer thereof in preparation of drug for promoting nerve growth and repair | Inactive | 12-Jul-2023 | A61K31/765 |
Sinobiom Signals
Sinobiom Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Sino-Ocean Capital | Asset Manager | Minority | ||
| Changchun Financial Holding Group | Government | Minority |
Sinobiom FAQs
-
When was Sinobiom founded?
Sinobiom was founded in 2007.
-
Where is Sinobiom headquartered?
Sinobiom is headquartered in Changchun, China.
-
What is the size of Sinobiom?
Sinobiom has 135 total employees.
-
What industry is Sinobiom in?
Sinobiom’s primary industry is Medical Supplies.
-
Is Sinobiom a private or public company?
Sinobiom is a Private company.
-
What is Sinobiom’s current revenue?
The current revenue for Sinobiom is .
-
How much funding has Sinobiom raised over time?
Sinobiom has raised $30.9M.
-
Who are Sinobiom’s investors?
Sino-Ocean Capital and Changchun Financial Holding Group have invested in Sinobiom.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process